ArticleOPEN ACCESS

Heparan sulfate: A stem cell therapy target?

Blood
DOI: 10.1182/blood-2014-09-601401
1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Saez et al demonstrate that inhibition of heparan sulfate proteoglycan production by bone marrow osteolineage stromal cells results in hematopoietic stem cell egress from the bone marrow niche into the peripheral circulation.

Cite

CITATION STYLE

APA

Olson, T. S. (2014, November 6). Heparan sulfate: A stem cell therapy target? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2014-09-601401

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free